Furthermore, TMEFF2 inhibited the production of adrenocorticotropic hormone (ACTH) in response to CRH (corticotropin releasing hormone) stimulation in AtT20 glioma cells; this action was demonstrated to be the result of TMEFF2-imparted action at multiple levels of CRHR1 signalling. This evidence concerns the gene TMEFF2 and central nervous system cancer.